China clears AI-assisted drug in pharmaceutical milestone
Chinese regulators have conditionally approved a COVID-19 treatment described by state media as the country’s first Class 1 innovative drug developed with the assistance of artificial intelligence. The National Medical Products Administration cleared Mprosevir for adults with mild to moderate COVID-19, according to the state-run Global Times. The medicine was jointly developed by Westlake University,…